tranylcypromine has been researched along with oxazoles in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Da Prada, M; Keller, HH; Kettler, R | 1 |
Palm, D; Planz, G; Quiring, K | 1 |
Grewal, RS; Kaul, CL | 1 |
Benedetti, MS; Dostert, P; Guffroy, C; Tipton, KF | 1 |
Ancher, JF; Benedetti, MS; Sontag, N | 1 |
Benedetti, MS; Kan, JP | 1 |
6 other study(ies) available for tranylcypromine and oxazoles
Article | Year |
---|---|
[Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Benzamides; Blood Pressure; Heart Rate; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Piperidines; Rats; Serotonin; Structure-Activity Relationship; Tranylcypromine | 1989 |
Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol.
Topics: Amines; Animals; Benzoates; Benzyl Compounds; Brain; Half-Life; Hydrazines; Isoproterenol; Kinetics; Male; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Nialamide; Organ Size; Oxazoles; Pargyline; Rats; Submandibular Gland; Tranylcypromine | 1972 |
Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
Topics: Amines; Animals; Antihypertensive Agents; Blood Pressure; Brain; Brain Chemistry; Cats; Dogs; Dopamine; Drug Synergism; Formates; Ketones; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Norepinephrine; Oxazoles; Proadifen; Pyridines; Pyrimidinones; Rats; Serotonin; Tranylcypromine; Tyramine | 1972 |
Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236.
Topics: Animals; Brain; Clorgyline; Dose-Response Relationship, Drug; Female; Liver; Male; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Selegiline; Tranylcypromine | 1983 |
Monoamine oxidase inhibitors and histamine metabolism.
Topics: Animals; Clorgyline; Histamine; Iproniazid; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Selegiline; Tranylcypromine | 1980 |
Antagonism between long acting monoamine oxidase inhibitors (MAOI) and MD780515, a new specific and reversible MAOI.
Topics: Animals; Brain; Clorgyline; Drug Interactions; Liver; Male; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Oxazolidinones; Rats; Serotonin; Time Factors; Tranylcypromine | 1980 |